casemark/evaluating-post-reorganization-equity

Evaluating Post Reorganization Equity

Assesses post-emergence equity with clean balance sheet analysis, improved capital structure, and re-rating potential.

When To Use

• A company has recently emerged or is about to emerge from Chapter 11 reorganization
• Evaluating whether to take a position in newly issued post-reorg equity
• Assessing re-rating potential as the company transitions from distressed to performing credit
• Comparing emergence equity to pre-petition recovery estimates or plan of reorganization projections
• Screening event-driven opportunities in freshly reorganized companies with limited analyst coverage

Inputs To Gather

• Plan of Reorganization (POR): Confirmed plan detailing new capital structure, equity distribution, and creditor recoveries
• Emergence Balance Sheet: Pro forma or actual day-one balance sheet showing fresh-start accounting adjustments
• Disclosure Statement Projections: Management or financial advisor forecasts used to solicit plan votes
• New Equity Details: Share count, warrants, management incentive plans (MIPs), rights offerings, backstop commitments
• Pre-Petition Debt Schedule: Original capital structure to understand deleveraging magnitude
• Industry Comps: Trading multiples for healthy peers in the same sector
• Post-Emergence 8-K / 10-K: First public filings after emergence, including fresh-start adjustments [VERIFY availability depending on whether company remains a reporting issuer]
• Creditor Recovery Analysis: Actual vs. estimated recoveries by class to gauge residual equity value

Workflow

1. Map the New Capital Structure

   • Document total debt, net debt, and leverage ratios at emergence
   • Identify all equity tranches: common shares, warrants (strike prices, expiration), MIP pools, and any convertible instruments
   • Calculate fully diluted share count including all potential dilution sources
   • Compare emergence leverage to industry medians and the company's own pre-distress levels

2. Analyze the Clean Balance Sheet

   • Review fresh-start accounting adjustments: asset revaluations, goodwill write-offs, liability extinguishments
   • Identify any retained liabilities that survived reorganization (environmental, pension, litigation reserves) [VERIFY specific liability treatment per confirmed plan]
   • Assess working capital adequacy and exit facility terms (revolver availability, covenants)
   • Flag any material contingent liabilities or ongoing administrative claims

3. Evaluate Operational Trajectory

   • Compare disclosure statement projections against actual post-emergence performance (revenue, EBITDA, margins)
   • Identify operational improvements implemented during restructuring: cost cuts, asset divestitures, management changes
   • Assess whether the business model issues that caused distress have been structurally resolved vs. temporarily masked by debt relief
   • Review capex requirements and deferred maintenance that may compress near-term free cash flow

4. Estimate Intrinsic Value and Re-Rating Potential

   • Apply peer-group EV/EBITDA multiples to normalized post-emergence EBITDA
   • Discount the multiple to reflect post-reorg execution risk, governance uncertainty, and limited trading history
   • Build a re-rating bridge: current distressed multiple → target normalized multiple, with timeline and catalysts
   • Run sensitivity analysis across EBITDA scenarios and multiple expansion assumptions
   • Calculate equity value per share on a fully diluted basis, net of any remaining warrants and MIP dilution

5. Assess Technical and Structural Factors

   • Evaluate expected shareholder base: forced sellers (creditors receiving equity who don't hold equities), potential index inclusion timeline, analyst coverage initiation
   • Gauge liquidity: float size, average daily volume, lock-up restrictions on insider shares
   • Identify catalyst timeline: first earnings report, debt refinancing, asset sales, potential M&A interest
   • Consider governance quality: new board composition, management team track record, shareholder rights provisions

Output

Produce an Evaluation Report containing:

• Executive Summary: One-paragraph investment thesis with target valuation range and key catalysts
• Capital Structure Table: Pre-petition vs. post-emergence comparison showing deleveraging impact
• Valuation Summary: Base / bull / bear equity value per share with underlying assumptions
• Re-Rating Bridge: Visual or tabular depiction of current implied multiple → target multiple with catalysts
• Risk Factors: Ranked list of downside risks (operational underperformance, re-levering, governance issues, forced selling pressure)
• Catalyst Timeline: Key dates and events that could drive re-rating over 6-18 months
• Recommendation: Actionable positioning view (long equity, wait for catalyst, hedge via warrants, avoid)

Quality Checks

• Fully diluted share count matches POR distributions and accounts for all warrants, MIP grants, and rights offering shares
• Fresh-start accounting adjustments are reflected consistently in both balance sheet and valuation inputs
• Leverage ratios use the correct debt figures (gross vs. net, including or excluding exit facility draws)
• Valuation comps use appropriate peer set — not comparing asset-light businesses to capital-intensive ones
• Disclosure statement projections are tested against actual results where post-emergence data is available
• All jurisdiction-specific plan provisions (tax attributes, NOL preservation under Section 382, successor liability) are flagged with [VERIFY]
• Forced-seller dynamics and float constraints are explicitly addressed in the technical assessment